Extent of pelvic lymph node dissection in penile cancer may impact survival

详细信息    查看全文

• 作者：Kamran Zargar-Shoshtari ; Pranav Sharma ; Rosa Djajadiningrat…
• 关键词：Penile neoplasms ; Lymph node excision ; Algorithms
• 刊名：World Journal of Urology
• 出版年：2016
• 出版时间：March 2016
• 年：2016
• 卷：34
• 期：3
• 页码：353-359
• 全文大小：528 KB
• 参考文献：1.Lopes A, Bezerra AL, Serrano SV, Hidalgo GS (2000) Iliac nodal metastases from carcinoma of the penis treated surgically. BJU Int 86(6):690–693CrossRef PubMed
  2.Pandey D, Mahajan V, Kannan RR (2006) Prognostic factors in node-positive carcinoma of the penis. J Surg Oncol 93(2):133–138. doi:10.​1002/​jso.​20414 CrossRef PubMed
  3.Lopes A, Hidalgo GS, Kowalski LP, Torloni H, Rossi BM, Fonseca FP (1996) Prognostic factors in carcinoma of the penis: multivariate analysis of 145 patients treated with amputation and lymphadenectomy. J Urol 156(5):1637–1642CrossRef PubMed
  4.Sanchez-Ortiz RF, Pettaway CA (2004) The role of lymphadenectomy in penile cancer. Urol Oncol 22(3):236–244; (discussion 244–235). doi:10.​1016/​j.​urolonc.​2004.​04.​031 CrossRef PubMed
  5.Lont AP, Kroon BK, Gallee MP, van Tinteren H, Moonen LM, Horenblas S (2007) Pelvic lymph node dissection for penile carcinoma: extent of inguinal lymph node involvement as an indicator for pelvic lymph node involvement and survival. J Urol 177(3):947–952; (discussion 952). doi:10.​1016/​j.​juro.​2006.​10.​060 CrossRef PubMed
  6.Lughezzani G, Catanzaro M, Torelli T, Piva L, Biasoni D, Stagni S, Crestani A, Guttilla A, Raggi D, Giannatempo P, Necchi A, Pizzocaro G, Colecchia M, Salvioni R, Nicolai N (2014) The relationship between characteristics of inguinal lymph nodes and pelvic lymph node involvement in penile squamous cell carcinoma: a single institution experience. J Urol 191(4):977–982. doi:10.​1016/​j.​juro.​2013.​10.​140 CrossRef PubMed
  7.Hakenberg OW, Comperat EM, Minhas S, Necchi A, Protzel C, Watkin N (2015) EAU guidelines on penile cancer: 2014 update. Eur Urol 67(1):142–150. doi:10.​1016/​j.​eururo.​2014.​10.​017 CrossRef PubMed
  8.Clark PE, Spiess PE, Agarwal N, Biagioli MC, Eisenberger MA, Greenberg RE, Herr HW, Inman BA, Kuban DA, Kuzel TM, Lele SM, Michalski J, Pagliaro L, Pal SK, Patterson A, Plimack ER, Pohar KS, Porter MP, Richie JP, Sexton WJ, Shipley WU, Small EJ, Trump DL, Wile G, Wilson TG, Dwyer M, Ho M, National Comprehensive Cancer N (2013) Penile cancer: clinical practice guidelines in oncology. J Natl Compr Cancer Netw 11(5):594–615
  9.Zhu Y, Zhang SL, Ye DW, Yao XD, Dai B, Zhang HL, Shen YJ, Zhu YP, Shi GH, Ma CG (2009) Prospectively packaged ilioinguinal lymphadenectomy for penile cancer: the disseminative pattern of lymph node metastasis. J Urol 181(5):2103–2108. doi:10.​1016/​j.​juro.​2009.​01.​041 CrossRef PubMed
  10.Liu JY, Li YH, Zhang ZL, Yao K, Ye YL, Xie D, Han H, Liu ZW, Qin ZK, Zhou FJ (2013) The risk factors for the presence of pelvic lymph node metastasis in penile squamous cell carcinoma patients with inguinal lymph node dissection. World J Urol 31(6):1519–1524. doi:10.​1007/​s00345-013-1024-4 CrossRef PubMed
  11.Pagliaro LC, Williams DL, Daliani D, Williams MB, Osai W, Kincaid M, Wen S, Thall PF, Pettaway CA (2010) Neoadjuvant paclitaxel, ifosfamide, and cisplatin chemotherapy for metastatic penile cancer: a phase II study. J Clin Oncol 28(24):3851–3857. doi:10.​1200/​JCO.​2010.​29.​5477 PubMedCentral CrossRef PubMed
  12.Leijte JA, Kerst JM, Bais E, Antonini N, Horenblas S (2007) Neoadjuvant chemotherapy in advanced penile carcinoma. Eur Urol 52(2):488–494. doi:10.​1016/​j.​eururo.​2007.​02.​006 CrossRef PubMed
  13.Bermejo C, Busby JE, Spiess PE, Heller L, Pagliaro LC, Pettaway CA (2007) Neoadjuvant chemotherapy followed by aggressive surgical consolidation for metastatic penile squamous cell carcinoma. J Urol 177(4):1335–1338. doi:10.​1016/​j.​juro.​2006.​11.​038 CrossRef PubMed
  14.Noronha V, Patil V, Ostwal V, Tongaonkar H, Bakshi G, Prabhash K (2012) Role of paclitaxel and platinum-based adjuvant chemotherapy in high-risk penile cancer. Urol Ann 4(3):150–153. doi:10.​4103/​0974-7796.​102659 PubMedCentral CrossRef PubMed
  15.Pizzocaro G, Piva L, Bandieramonte G, Tana S (1997) Up-to-date management of carcinoma of the penis. Eur Urol 32(1):5–15PubMed
  16.Franks KN, Kancherla K, Sethugavalar B, Whelan P, Eardley I, Kiltie AE (2011) Radiotherapy for node positive penile cancer: experience of the Leeds teaching hospitals. J Urol 186(2):524–529. doi:10.​1016/​j.​juro.​2011.​03.​117 CrossRef PubMed
  17.Karl A, Carroll PR, Gschwend JE, Knuchel R, Montorsi F, Stief CG, Studer UE (2009) The impact of lymphadenectomy and lymph node metastasis on the outcomes of radical cystectomy for bladder cancer. Eur Urol 55(4):826–835. doi:10.​1016/​j.​eururo.​2009.​01.​004 CrossRef PubMed
  18.Tarin TV, Power NE, Ehdaie B, Sfakianos JP, Silberstein JL, Savage CJ, Sjoberg D, Dalbagni G, Bochner BH (2012) Lymph node-positive bladder cancer treated with radical cystectomy and lymphadenectomy: effect of the level of node positivity. Eur Urol 61(5):1025–1030. doi:10.​1016/​j.​eururo.​2012.​01.​049 PubMedCentral CrossRef PubMed
  19.Dhar NB, Klein EA, Reuther AM, Thalmann GN, Madersbacher S, Studer UE (2008) Outcome after radical cystectomy with limited or extended pelvic lymph node dissection. J Urol 179(3):873–878; (discussion 878). doi:10.​1016/​j.​juro.​2007.​10.​076 CrossRef PubMed
  20.Leissner J, Hohenfellner R, Thuroff JW, Wolf HK (2000) Lymphadenectomy in patients with transitional cell carcinoma of the urinary bladder; significance for staging and prognosis. BJU Int 85(7):817–823CrossRef PubMed
  21.Herr HW, Faulkner JR, Grossman HB, Natale RB, deVere White R, Sarosdy MF, Crawford ED (2004) Surgical factors influence bladder cancer outcomes: a cooperative group report. J Clin Oncol 22(14):2781–2789. doi:10.​1200/​JCO.​2004.​11.​024 CrossRef PubMed
  22.Herr HW, Bochner BH, Dalbagni G, Donat SM, Reuter VE, Bajorin DF (2002) Impact of the number of lymph nodes retrieved on outcome in patients with muscle invasive bladder cancer. J Urol 167(3):1295–1298CrossRef PubMed
  23.Herr HW, Donat SM (2001) Outcome of patients with grossly node positive bladder cancer after pelvic lymph node dissection and radical cystectomy. J Urol 165(1):62–64; (discussion 64). doi:10.​1097/​00005392-200101000-00015 CrossRef PubMed
  24.Svatek RS, Munsell M, Kincaid JM, Hegarty P, Slaton JW, Busby JE, Gaston KE, Spiess PE, Pagliaro LC, Tamboli P, Pettaway CA (2009) Association between lymph node density and disease specific survival in patients with penile cancer. J Urol 182(6):2721–2727. doi:10.​1016/​j.​juro.​2009.​08.​029 CrossRef PubMed
  25.Davies JD, Simons CM, Ruhotina N, Barocas DA, Clark PE, Morgan TM (2013) Anatomic basis for lymph node counts as measure of lymph node dissection extent: a cadaveric study. Urology 81(2):358–363. doi:10.​1016/​j.​urology.​2012.​10.​025 CrossRef PubMed
  
• 作者单位：Kamran Zargar-Shoshtari (1)
  Pranav Sharma (1)
  Rosa Djajadiningrat (2)
  Mario Catanzaro (3)
  Ding-Wei Ye (4)
  Yao Zhu (4)
  Nicola Nicolai (3)
  Simon Horenblas (2)
  Philippe E. Spiess (1)
  
  1. Department of Genitourinary Oncology, Moffitt Cancer Center, 12902 Magnolia Drive Office 12538, Tampa, FL, 33612, USA
  2. Department of Urology, Netherlands Cancer Institute- Antoni van Leeuwenhoek Hospital, Amsterdam, The Netherlands
  3. Department of Urology, Fondazione IRCCS Istituto Nazionale Tumori, Milan, Italy
  4. Fudan University Shanghai Cancer Center, Department of Urology, Shanghai, China
  
• 刊物类别：Medicine
• 刊物主题：Medicine & Public Health
  Urology and Andrology
  Nephrology
  Oncology
  
• 出版者：Springer Berlin / Heidelberg
• ISSN：1433-8726

文摘

Introduction Current guidelines on management of penile carcinoma (PC) recommend ipsilateral pelvic lymph node dissection (PLND) in patients with inguinal lymph node metastasis (LNM) who meet specific criteria. The aim of this article was to assess outcomes in patients treated with bilateral PLND in the presence of unilateral metastatic pelvic nodes.